See also this year's filing and all EDGAR filings for this company.
PDF Report 0001100412_2018_ARRAY_BIOPHARMA_INC.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001100412')"} |
Graph
Absolute values for 0001100412, ARRAY BIOPHARMA INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 270,177,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 8,132,000 |
| 3 | remainder_Assets | 836,000 |
| 4 | LiabilitiesCurrent | 69,551,000 |
| 5 | LiabilitiesNoncurrent | 197,867,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 35,395,000 |
| 8 | SellingGeneralAndAdministrativeExpense | 39,336,000 |
| 9 | ResearchAndDevelopmentExpense | 178,199,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 150,852,000 |
| 12 | remainder_NetIncome | -14,740,000 |
| 13 | remainder_ComprehensiveNetIncome | -83,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 279,145,000 |
| 1 | Liabilities | 267,418,000 |
| 2 | Expenses | 252,930,000 |
| 3 | Revenues | 150,852,000 |
| 4 | StockholdersEquity | 11,727,000 |
| 5 | NetIncome | -116,818,000 |
| 6 | ComprehensiveNetIncome | -116,859,500 |
| 7 | BaseVar | 482,584,000 |
| 8 | EconomicCapitalRatio | -0.354 |